Q3 FY26 production; dispatches were 364 MW. H1 FY26 was ~360 MW.
Insolation Energy Ltd — Q3 FY26
Insolation Energy delivered a strong Q3 FY26 with revenue of ₹575 crore (+77% YoY) and EBITDA of ₹81.7 crore (+175% YoY), with EBITDA margin expanding 560 bps to 14.2%.
✓ Verified against BSE filing
2-Min Summary
Insolation Energy delivered a strong Q3 FY26 with revenue of ₹575 crore (+77% YoY) and EBITDA of ₹81.7 crore (+175% YoY), with EBITDA margin expanding 560 bps to 14.2%. Growth was driven by higher dispatches (364 MW) from the new INA3 line and improved operating leverage. The order book stands at 2.1 GW, providing 6-9 months visibility. Management guided for 40-45% revenue CAGR and sustained EBITDA margins of 14.5-15% (ex-cell). The 4.5 GW cell plant at Nirmadapuram is on track for Q3 FY27 commissioning, expected to add 400-500 bps to margins. Key risk: rapid price volatility in polysilicon and solar cells could pressure fixed-price order profitability.
Key Numbers
Provides 6-9 months visibility; management notes difficulty in maintaining longer fixed-price orders.
Includes new 1.5 GW line commissioned in December 2025 at INA3.
Success rate for tenders/quotes; management cited strong brand presence.
Management Guidance
Revenue CAGR of 40-45% over medium term
Management expects to sustain 40-45% revenue CAGR, targeting $1 billion (₹8,000 crore) top line in 2-3 years.
revenueQ4 FY26 dispatches of 450-500 MW
Management guided for dispatches of 450-500 MW in Q4 FY26, up from 364 MW in Q3.
growthCell plant commissioning in Q3 FY27
The 4.5 GW cell plant at Nirmadapuram is expected to be commissioned in Q3 FY27, with full ramp-up in 3 months.
expansionEBITDA margin expansion of 400-500 bps with cell integration
Once cell production starts, EBITDA margins are expected to increase by 400-500 bps, reaching ~20%.
marginsKey Risks
Raw material price volatility
Rapid changes in polysilicon and solar cell prices make it difficult to maintain long-term fixed-price orders, potentially squeezing margins.
high · management_commentaryDelay in cell plant commissioning
The cell plant is critical for margin expansion; any delay beyond Q3 FY27 could impact profitability targets.
medium · analyst_questionOvercapacity concerns in solar manufacturing
Despite management's rebuttal, industry overcapacity could lead to pricing pressure and lower capacity utilization.
medium · analyst_questionRevenue guidance miss for FY26
Management revised FY26 revenue guidance down to ~₹2,000 crore from earlier ₹3,300 crore due to capacity ramp-up delays.
high · data_observationNotable Quotes
Our mission is to become India's leading clean tech solution provider setting the benchmark in integrated solar manufacturing while delivering technology solutions globally.
The sustained EBITDA margin will be in the range of 14 and a half to 15%.
There is a myth in India that there is over capacity of solar panel manufacturing in our country.